Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters_kluwer/endothelial-factors-in-the-pathogenesis-and-treatment-of-chronic-jg0LJrB0Di
References (149)
-
V. D’Agati, A. Chagnac, A. Vries, M. Levi, E. Porrini, M. Herman-Edelstein, M. Praga (2016)
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesisNature Reviews Nephrology, 12
-
H. Seki (2014)
Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsiaActa Obstetricia et Gynecologica Scandinavica, 93
-
Y. Masuda, A. Shimizu, T. Mori, T. Ishiwata, H. Kitamura, R. Ohashi, M. Ishizaki, G. Asano, Y. Sugisaki, N. Yamanaka (2001)
Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.The American journal of pathology, 159 2
-
C. Zoccali, C. Torino, G. Curatola, V. Panuccio, R. Tripepi, P. Pizzini, M. Versace, D. Bolignano, S. Cutrupi, Lorenzo Ghiadoni, Ravi Thadhani, G. Tripepi, F. Mallamaci (2016)
Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients.Nutrition, metabolism, and cardiovascular diseases : NMCD, 26 7
-
Feng Li, J. Hagaman, H. Kim, N. Maeda, J. Jennette, J. Faber, S. Karumanchi, O. Smithies, Nobuyuki Takahashi (2012)
eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.Journal of the American Society of Nephrology : JASN, 23 4
-
Burnett (2009)
245J Urol, 181
-
(2012)
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1, 25
-
(2014)
The reninangiotensin-aldosterone system in preeclampsia: the delicate balance between good and bad -
L. Saleh, K. Verdonk, W. Visser, A. Meiracker, A. Danser (2016)
The emerging role of endothelin-1 in the pathogenesis of pre-eclampsiaTherapeutic Advances in Cardiovascular Disease, 10
-
Jeanie Park, Peizhou Liao, Salman Sher, R. Lyles, Don Deveaux, A. Quyyumi (2015)
Tetrahydrobiopterin lowers muscle sympathetic nerve activity and improves augmentation index in patients with chronic kidney disease.American journal of physiology. Regulatory, integrative and comparative physiology, 308 3
-
K. Schjoedt, S. Andersen, P. Rossing, L. Tarnow, H. Parving (2004)
Aldosterone escape during blockade of the renin–angiotensin–aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rateDiabetologia, 47
-
K. Okada, Y. Nishida, H. Murakami, I. Sugimoto, H. Kosaka, H. Morita, C. Yamashita, M. Okada (1998)
Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts: antiproliferative effects of bosentan, a nonselective endothelin receptor antagonist.Circulation, 97 23
-
J. Curtis, R. Luke, H. Dustan, M. Kashgarian, J. Whelchel, Patsy Jones, A. Diethelm (1983)
Remission of essential hypertension after renal transplantation.The New England journal of medicine, 310 13
-
A. Hishida, R. Okada, Yin Guang, M. Naito, K. Wakai, S. Hosono, Kazuyo Nakamura, T. Turin, Sadao Suzuki, H. Niimura, H. Mikami, Jun Otonari, N. Kuriyama, Sakurako Katsuura, M. Kubo, Hideo Tanaka, N. Hamajima (2013)
MTHFR, MTR and MTRR polymorphisms and risk of chronic kidney disease in Japanese: cross-sectional data from the J-MICC StudyInternational Urology and Nephrology, 45
-
F. Perticone, R. Maio, G. Tripepi, C. Zoccali (2004)
Endothelial Dysfunction and Mild Renal Insufficiency in Essential HypertensionCirculation, 110
-
T. Nakatani, S. Tanabe, Young-Sin Han, S. Kayo, N. Yoshimi, E. Hai, N. Shirai, Y. Ikura, M. Ohsawa, M. Ueda (2003)
Enhanced expression of endothelin-A receptor in human transplant renal arteriosclerosis.International journal of molecular medicine, 11 2
-
M. Cesari, M. Zanchetta, A. Burlina, L. Pedon, G. Maiolino, D. Sticchi, A. Pessina, G. Rossi (2004)
Hyperhomocysteinemia Is Inversely Related With Left Ventricular Ejection Fraction and Predicts Cardiovascular Mortality in High-Risk Coronary Artery Disease HypertensivesArteriosclerosis, Thrombosis, and Vascular Biology, 25
-
G. Sahin, O. Akay, S. Uslu, C. Bal, A. Yalçın, Z. Gulbaş (2015)
Association between endothelial and platelet function markers and adiponectin in renal transplanted recipients on cyclosporine and tacrolimus immunosuppression based therapyNephrology, 20
-
P. Frosst, H. Blom, R. Milos, P. Goyette, C. Sheppard, R. Matthews, G. Boers, M. Heijer, L. Kluijtmans, L. Heuve, R. Rozen (1995)
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 10
-
M. Barton (2008)
Reversal of proteinuric renal disease and the emerging role of endothelinNature Clinical Practice Nephrology, 4
-
A. Gregory, G. Xu, Valentin Sotov, Michelle Letarte (2014)
Review: the enigmatic role of endoglin in the placenta.Placenta, 35 Suppl
-
F. Stockenhuber, M. Gottsauner‐Wolf, L. Marosi, B. Liebisch, R. Kurz, P. Balcke (1992)
Plasma levels of endothelin in chronic renal failure and after renal transplantation: impact on hypertension and cyclosporin A-associated nephrotoxicity.Clinical science, 82 3
-
N. Silswal, C. Touchberry, D. Daniel, D. McCarthy, Shiqin Zhang, J. Andresen, Jason Stubbs, M. Wacker (2014)
FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.American journal of physiology. Endocrinology and metabolism, 307 5
-
M. Yılmaz, A. Sonmez, M. Sağlam, H. Yaman, S. Kılıç, T. Eyileten, K. Çağlar, Y. Oğuz, A. Vural, M. Yenıcesu, F. Mallamaci, C. Zoccali (2012)
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.American journal of kidney diseases : the official journal of the National Kidney Foundation, 59 2
-
D. Uhlmann, S. Ludwig, E. Escher, B. Armann, G. Gäbel, D. Teupser, A. Tannapfel, J. Hauss, H. Witzigmann (2001)
Protective effect of a selective endothelin a receptor antagonist (BSF 208075) on graft pancreatitis in pig pancreas transplantation.Transplantation proceedings, 33 7-8
-
K. Fukunaga, Y. Takada, H. Taniguchi, K. Yuzawa, M. Otsuka, T. Todoroki, K. Goto, K. Fukao (1998)
Protecting the viability of hepatic allografts procured from non-heart-beating donors by blockade of endothelin and platelet activating factor in porcine liver transplantation.International surgery, 83 3
-
Matthias Meyer, M. Barton (2018)
GPER blockers as Nox downregulators: A new drug class to target chronic non-communicable diseasesThe Journal of Steroid Biochemistry and Molecular Biology, 176
-
M. Fung, R. Salem, M. Lipkowitz, V. Bhatnagar, Braj Pandey, N. Schork, D. O'Connor (2012)
Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27 1
-
B. Brenner, M. Cooper, D. Zeeuw, W. Keane, W. Mitch, H. Parving, G. Remuzzi, S. Snapinn, Zhonxin Zhang, S. Shahinfar (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.The New England journal of medicine, 345 12
-
A. El, Nahas Frcp, A. Bello, A. Meguid, El Nahas, A. Bello (2005)
Chronic kidney disease: the global challengeThe Lancet, 365
-
Monica Cortinovis, P. Ruggenenti, G. Remuzzi (2016)
Progression, Remission and Regression of Chronic Renal DiseasesNephron, 134
-
A. Zarbock, C. Schmidt, H. Aken, C. Wempe, S. Martens, P. Zahn, B. Wolf, U. Goebel, C. Schwer, P. Rosenberger, H. Haeberle, D. Görlich, J. Kellum, M. Meersch (2015)
Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial.JAMA, 313 21
-
Richard Johnson, M. Nangaku (2016)
Endothelial Dysfunction: The Secret Agent Driving Kidney Disease.Journal of the American Society of Nephrology : JASN, 27 1
-
A. Tawakol, T. Omland, M. Gerhard, James Wu, M. Creager (1997)
Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.Circulation, 95 5
-
S. Nielsen, K. Schjoedt, K. Rossing, F. Persson, C. Schalkwijk, C. Stehouwer, H. Parving, P. Rossing (2013)
Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney diseaseJournal of the Renin-Angiotensin-Aldosterone System, 14
-
E. Tapia, L. Sánchez-Lozada, Virgilia Soto, Andrés Manrique, K. Ortiz-Vega, J. Santamaría, O. Medina-Campos, Magdalena Cristóbal, C. Avila-Casado, J. Pedraza-Chaverri, B. Rodriguez-Iturbe, Martha Franco (2012)
Sildenafil Treatment Prevents Glomerular Hypertension and Hyperfiltration in Rats with Renal AblationKidney and Blood Pressure Research, 35
-
H. MacLaughlin, W. Hall, J. Condry, T. Sanders, I. Macdougall (2015)
Participation in a Structured Weight Loss Program and All-Cause Mortality and Cardiovascular Morbidity in Obese Patients With Chronic Kidney Disease.Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 25 6
-
D. Zeeuw, B. Coll, D. Andress, J. Brennan, H. Tang, M. Houser, R. Correa-Rotter, D. Kohan, H. Heerspink, H. Makino, V. Perkovic, Y. Pritchett, G. Remuzzi, S. Tobe, R. Toto, G. Viberti, H. Parving (2014)
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.Journal of the American Society of Nephrology : JASN, 25 5
-
Orth (1999)
387J Am Soc Nephrol, 10
-
M. Kappers, F. Smedts, T. Horn, J. Esch, S. Sleijfer, F. Leijten, S. Wesseling, H. Strevens, A. Danser, A. Meiracker (2011)
The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin SystemHypertension, 58
-
S. Nielsen, F. Persson, E. Frandsen, T. Sugaya, G. Hess, D. Zdunek, Shjoedt Kj, H. Parving, P. Rossing (2012)
Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo‐controlled crossover studyDiabetic Medicine, 29
-
S. Textor, V. Canzanello, S. Taler, D. Wilson, L. Schwartz, J. Augustine, J. Raymer, J. Romero, R. Wiesner, R. Krom, J. Burnett (1994)
Cyclosporine-induced hypertension after transplantation.Mayo Clinic proceedings, 69 12
-
Schepkens (2001)
438Am J Med, 110
-
E. Lewis, L. Hunsicker, W. Clarke, T. Berl, M. Pohl, J. Lewis, E. Ritz, R. Atkins, R. Rohde, I. Raz (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.The New England journal of medicine, 345 12
-
Nakatani (2003)
153Int J Mol Med, 11
-
(2010)
Preeclampsia, 376
-
Mihran Naljayan, S. Karumanchi (2013)
New developments in the pathogenesis of preeclampsia.Advances in chronic kidney disease, 20 3
-
Fukunaga (1998)
226Int Surg, 83
-
H. Parving, Hendrik Lehnert, J. Bröchner-Mortensen, R. Gomis, S. Andersen, P. Arner (2001)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.The New England journal of medicine, 345 12
-
Khosla (2009)
418Am J Nephrol, 30
-
C. Braun, Tobias Conzelmann, Stephan Vetter, Meike Schaub, W. Back, B. Yard, Michael Kirchengast, S. Tullius, Peter Schn??lle, Fokko Woude, Peter Rohmeiss (1999)
Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.Transplantation, 68 6
-
K. Sydow, T. Münzel (2003)
ADMA and oxidative stress.Atherosclerosis. Supplements, 4 4
-
Marion Weis, SM Wildhirt, C. Schulze, Gabriele Rieder, Ute Wilbert-Lampen, Wolf-Peter Wolf, R. Arendt, Georg Enders, Bruno Meiser, W. Scheidt (1999)
Endothelin in coronary endothelial dysfunction early after human heart transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 18 11
-
K. Kumano, N. Masui, S. Soh, S. Mashimo, T. Endo (1994)
Plasma endothelin level following kidney transplantation.Transplantation proceedings, 26 4
-
Nilka Jesús-González, Emily Robinson, R. Penchev, M. Mehren, M. Heinrich, W. Tap, Qian Wang, G. Demetri, S. George, B. Humphreys
Nature Publishing Group Original Contributions Regorafenib Induces Rapid and Reversible Changes in Plasma Nitric Oxide and Endothelin-1 -
K. Fukunaga, Y. Takada, H. Taniguchi, M. Otsuka, K. Fukao (1999)
Endothelin antagonist improves viability of liver grafts from non-heart-beating donors.Transplantation proceedings, 31 1-2
-
Bharathy Ponnuchamy, R. Khalil (2009)
Cellular mediators of renal vascular dysfunction in hypertension.American journal of physiology. Regulatory, integrative and comparative physiology, 296 4
-
V. Schini-Kerth (2003)
Homocysteine, a proinflammatory and proatherosclerotic factor: role of intracellular reactive oxygen species.Circulation research, 93 4
-
V. Patel, Srinivas Panja, A. Venkataraman (2001)
The HOPE Study and MICRO-HOPE Substudy effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitusThe British Journal of Diabetes & Vascular Disease, 1
-
M. Yılmaz, A. Sonmez, M. Sağlam, H. Yaman, S. Kılıç, T. Turker, H. Unal, M. Gok, H. Cetinkaya, T. Eyileten, Y. Oğuz, K. Çağlar, A. Vural, F. Mallamaci, C. Zoccali (2013)
Longitudinal Analysis of Vascular Function and Biomarkers of Metabolic Bone Disorders before and after Renal TransplantationAmerican Journal of Nephrology, 37
-
C. Redman, I. Sargent (2005)
Latest Advances in Understanding PreeclampsiaScience, 308
-
S. Lankhorst, H. Baelde, M. Kappers, F. Smedts, Alastair Hansen, M. Groningen, S. Sleijfer, R. Mathijssen, A. Danser, A. Meiracker (2015)
Greater Sensitivity of Blood Pressure Than Renal Toxicity to Tyrosine Kinase Receptor Inhibition With SunitinibHypertension, 66
-
T. Lattmann, M. Hein, Sibylle Horber, J. Ortmann, M. Teixeira, D. Souza, E. Haas, L. Tornillo, K. Münter, W. Vetter, M. Barton (2005)
Activation of Pro‐Inflammatory and Anti‐Inflammatory Cytokines in Host Organs During Chronic Allograft Rejection: Role of Endothelin Receptor SignalingAmerican Journal of Transplantation, 5
-
D. Uhlmann, S. Ludwig, E. Escher, B. Armann, G. Gäbel, D. Teupser, A. Tannapfel, U. Pietsch, J. Hauss, H. Witzigmann (2002)
Attenuation of endothelin expression and histologic changes by administration of a selective endothelin-A receptor antagonist in pig pancreas transplantation.Transplantation proceedings, 34 6
-
S. Orth, G. Odoni, Kerstin Amann, Piotr Strzelczyk, Manfred Raschack, Eberhard Ritz (1999)
The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" model.Journal of the American Society of Nephrology : JASN, 10 2
-
Barbara Alexander, A. Rinewalt, K. Cockrell, Matthew Massey, William Bennett, Joey Granger (2001)
Endothelin Type A Receptor Blockade Attenuates the Hypertension in Response to Chronic Reductions in Uterine Perfusion PressureHypertension: Journal of the American Heart Association, 37
-
Wen-Hao Tang, Fu-Huang Lin, Chien-Hsing Lee, Feng-Chih Kuo, C. Hsieh, Fone-Ching Hsiao, Y. Hung (2014)
Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trialEndocrine, 45
-
R. Preston, I. Singer, Murray Epstein (1996)
Renal Parenchymal Hypertension: current concepts of pathogenesis and management.Archives of internal medicine, 156 6
-
Kristina Lundwall, G. Jörneskog, S. Jacobson, J. Spaak (2015)
Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized TrialAmerican Journal of Nephrology, 42
-
C. Haug, T. Duell, R. Voisard, A. Lenich, H. Kolb, V. Mickley, V. Hombach, A. Grünert (1995)
Cyclosporine A Stimulates Endothelin ReleaseJournal of Cardiovascular Pharmacology, 26
-
P. Aggarwal, N. Chandel, Vanita Jain, Vivekanand Jha (2012)
The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsiaJournal of Human Hypertension, 26
-
A. Hruby, J. Manson, L. Qi, Vasanti Malik, E. Rimm, Qi Sun, W. Willett, F. Hu (2016)
Determinants and Consequences of Obesity.American journal of public health, 106 9
-
Yanping Li, Tianyi Huang, Yan Zheng, T. Muka, Jenna Troup, F. Hu (2016)
Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta‐Analysis of Randomized Controlled TrialsJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 5
-
de Jesus-Gonzalez (2012)
1118Am J Hypertens, 25
-
Xin Xu, X. Qin, Youbao Li, Dan Sun, Jun Wang, M. Liang, Bin-yan Wang, Y. Huo, F. Hou (2016)
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.JAMA internal medicine, 176 10
-
Hai-chun Yang, A. Fogo (2014)
Fibrosis and renal agingKidney International Supplements, 4
-
D. Jalal, Emily Decker, L. Perrenoud, Kristen Nowak, Nina Bispham, T. Mehta, G. Smits, Zhiying You, D. Seals, M. Chonchol, Richard Johnson (2017)
Vascular Function and Uric Acid-Lowering in Stage 3 CKD.Journal of the American Society of Nephrology : JASN, 28 3
-
Lea Borgi, C. McMullan, Ann Wohlhueter, G. Curhan, N. Fisher, J. Forman (2017)
Effect of Uric Acid-Lowering Agents on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.Hypertension
-
A. Shindel (2010)
Serum Biomarker Measurements of Endothelial Function and Oxidative Stress After Daily Dosing of Sildenafil in Type 2 Diabetic Men With Erectile DysfunctionYearbook of Urology, 2010
-
C. Cruz, Á. Cruz, C. Souza (2003)
Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 18 9
-
Judith Adams, G. Odoni, H. Ogata, C. Viedt, K. Amann, E. Ritz, S. Orth (2002)
Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 17 5
-
A. Meiracker, R. Baggen, S. Pauli, A. Lindemans, A. Vulto, D. Poldermans, F. Boomsma (2006)
Spironolactone in type 2 diabetic nephropathy: effects on proteinuria, blood pressure and renal functionJournal of Hypertension, 24
-
G. Rossi, G. Maiolino, T. Seccia, A. Burlina, S. Zavattiero, M. Cesari, D. Sticchi, L. Pedon, M. Zanchetta, A. Pessina (2006)
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk womenJournal of Hypertension, 24
-
C. Gennari-Moser, E. Khankin, G. Escher, F. Burkhard, Brigitte Frey, S. Karumanchi, Felix Frey, Markus Mohaupt (2013)
Vascular Endothelial Growth Factor-A and Aldosterone: Relevance to Normal Pregnancy and PreeclampsiaHypertension, 61
-
R. Jamison, M. Shih, Donald Humphries, P. Guarino, J. Kaufman, D. Goldfarb, S. Warren, J. Gaziano, P. Lavori (2009)
Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.American journal of kidney diseases : the official journal of the National Kidney Foundation, 53 5
-
J. Pan, D. Sheikh-Hamad (2015)
Remote ischemic preconditioning for kidney protection.JAMA, 313 21
-
K. Matsuguma, S. Ueda, S. Yamagishi, Yuriko Matsumoto, Utako Kaneyuki, Ryo Shibata, Toshiko Fujimura, H. Matsuoka, M. Kimoto, S. Kato, T. Imaizumi, S. Okuda (2006)
Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.Journal of the American Society of Nephrology : JASN, 17 8
-
C. Desouza, Akhil Parulkar, D. Lumpkin, D. Akers, V. Fonseca (2002)
Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes.Diabetes care, 25 8
-
M. Yılmaz, M. Sağlam, K. Çağlar, E. Çakır, T. Ozgurtas, A. Sonmez, T. Eyileten, M. Yenıcesu, C. Açikel, Y. Oğuz, O. Ozcan, U. Bozlar, K. Erbil, I. Aslan, A. Vural (2005)
Endothelial Functions Improve with Decrease in Asymmetric Dimethylarginine (ADMA) Levels after Renal TransplantationTransplantation, 80
-
K. Polkinghorne, P. Branley, P. Kerr (2004)
Interventions for lowering plasma homocysteine levels in dialysis patientsCochrane Database of Systematic Reviews
-
G. Culshaw, I. MacIntyre, N. Dhaun, D. Webb (2015)
Endothelin in nondiabetic chronic kidney disease: preclinical and clinical studies.Seminars in nephrology, 35 2
-
C. Zoccali, S. Bode-Böger, F. Mallamaci, F. Benedetto, G. Tripepi, L. Malatino, A. Cataliotti, I. Bellanuova, I. Fermo, J. Frölich, R. Böger (2001)
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyThe Lancet, 358
-
H. Shennib, A. Lee, J. Kuang, M. Yanagisawa, E. Ohlstein, A. Giaid (1998)
Efficacy of administering an endothelin-receptor antagonist (SB209670) in ameliorating ischemia-reperfusion injury in lung allografts.American journal of respiratory and critical care medicine, 157 6 Pt 1
-
C. Braun, Tobias Conzelmann, Stephan Vetter, Meike Schaub, W. Back, M. Kirchengast, S. Tullius, Peter Schnülle, Fokko Woude, Peter Rohmeiss (2000)
Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats.Journal of cardiovascular pharmacology, 36 4
-
Eric Brunner, Martin Shipley, S. Ahmadi-Abhari, Á. Tabák, C. McEniery, Ian Wilkinson, M. Marmot, A. Singh‐Manoux, KM Adiposity (2015)
Adiposity, obesity, and arterial aging: longitudinal study of aortic stiffness in the Whitehall II cohort (vol 66, pg 294, 2015) -
C. Kwok, A. Pradhan, M. Khan, S. Anderson, B. Keavney, P. Myint, M. Mamas, Y. Loke (2014)
Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis.International journal of cardiology, 173 1
-
H. Schepkens, R. Vanholder, J. Billiouw, N. Lameire (2001)
Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.The American journal of medicine, 110 6
-
Matthias Meyer, Natalie Fredette, C. Daniel, Geetanjali Sharma, K. Amann, J. Arterburn, M. Barton, E. Prossnitz (2016)
Obligatory role for GPER in cardiovascular aging and diseaseScience Signaling, 9
-
Glenn Lee, Y. Cha (2016)
Cardiovascular benefits of bariatric surgery.Trends in cardiovascular medicine, 26 3
-
Kenneth Lamb, S. Lodhi, H. Meier‐Kriesche (2011)
Long‐Term Renal Allograft Survival in the United States: A Critical ReappraisalAmerican Journal of Transplantation, 11
-
(2013)
Impact of Nacetylcysteine on endothelial function, B-type natriuretic peptide and renal function in patients with the cardiorenal syndrome: a pilot cross over randomised controlled trial -
Verdonk (2014)
537Clin Sci (Lond, 126
-
C. Zoccali, G. Curatola, V. Panuccio, R. Tripepi, P. Pizzini, M. Versace, D. Bolignano, S. Cutrupi, R. Politi, G. Tripepi, L. Ghiadoni, R. Thadhani, F. Mallamaci (2014)
Paricalcitol and Endothelial Function in Chronic Kidney Disease TrialHypertension, 64
-
J. George, Elaine Carr, J Davies, Jill Belch, A. Struthers (2006)
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric AcidCirculation, 114
-
K. Verdonk, L. Saleh, S. Lankhorst, J. Smilde, M.M. Ingen, I. Garrelds, E. Friesema, H. Russcher, A. Meiracker, W. Visser, A. Danser (2015)
Association Studies Suggest a Key Role for Endothelin-1 in the Pathogenesis of Preeclampsia and the Accompanying Renin–Angiotensin–Aldosterone System SuppressionHypertension, 65
-
M. Litwin, J. Feber, A. Niemirska, J. Michalkiewicz (2015)
Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalitiesPediatric Nephrology (Berlin, Germany), 31
-
S. Textor, D. Wilson, A. Lerman, J. Romero, J. Burnett, R. Wiesner, E. Dickson, R. Krom (1992)
Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation.Transplantation, 54 1
-
Lilla Fang, T. Radovits, G. Szabó, M. Mózes, L. Rosivall, G. Kökény (2013)
Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 28 7
-
E. Ostrakhovitch, S. Tabibzadeh (2015)
Homocysteine in Chronic Kidney Disease.Advances in clinical chemistry, 72
-
Rabelink (1997)
11Drugs, 53
-
Sydney Murphy, Babbette LaMarca, K. Cockrell, J. Granger (2010)
Role of Endothelin in Mediating Soluble fms-Like Tyrosine Kinase 1–Induced Hypertension in Pregnant RatsHypertension, 55
-
D. Kohan, M. Barton (2014)
Endothelin and Endothelin Antagonists in Chronic Kidney DiseaseKidney international, 86
-
(2015)
Adiposity, obesity, and arterial aging: longitudinal study of aortic stiffness in the Whitehall II Cohort, 66
-
A. Belloni, G. Rossi, P. Andreis, G. Neri, G. Albertin, A. Pessina, G. Nussdorfer (1996)
Endothelin adrenocortical secretagogue effect is mediated by the B receptor in rats.Hypertension, 27 5
-
G. Dreyer, A. Tucker, S. Harwood, R. Pearse, M. Raftery, M. Yaqoob (2014)
Ergocalciferol and Microcirculatory Function in Chronic Kidney Disease and Concomitant Vitamin D Deficiency: An Exploratory, Double Blind, Randomised Controlled TrialPLoS ONE, 9
-
Maynard (2003)
649J Clin Invest, 111
-
F. Spradley, Ana Palei, J. Granger (2015)
Immune Mechanisms Linking Obesity and PreeclampsiaBiomolecules, 5
-
Y. Martin, O. Salavaggione, B. Eckloff, E. Wieben, D. Schaid, R. Weinshilboum (2006)
Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomicsPharmacogenetics and Genomics, 16
-
M. Stühlinger, R. Oka, DNSc Anp, E. Graf, I. Schmölzer, B. Upson, Om Kapoor, A. Szuba, M. Malinow, T. Wascher, O. Pachinger, J. Cooke (2003)
Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric DimethylarginineCirculation: Journal of the American Heart Association, 108
-
Desouza (2002)
1336Diabetes Care, 25
-
R. Rocha, C. Stier (2001)
Pathophysiological effects of aldosterone in cardiovascular tissuesTrends in Endocrinology & Metabolism, 12
-
A. Bostom, Lori Lathrop (1997)
Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.Kidney international, 52 1
-
T. Tomimatsu, K. Mimura, M. Endo, K. Kumasawa, T. Kimura (2017)
Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunctionHypertension Research, 40
-
S. Kim, J. Yang, Y. Kim, H. Shin, Y. Jung, H. Rim, Mi Kim, H. Rhew (2015)
SuO044PREDICTORS OF HYPERKALEMIA RISK FOLLOWING HYPERTENSION CONTROL WITH ALDOSTERONE BLOCKADENephrology Dialysis Transplantation, 30
-
N. Edwards, R. Steeds, C. Chue, P. Stewart, C. Ferro, J. Townend (2012)
The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease.British journal of clinical pharmacology, 73 3
-
Brunner (2015)
294Hypertension, 66
-
R. Gaston, S. Schlessinger, P. Sanders, C. Barker, J. Curtis, D. Warnock (1995)
Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients.Journal of the American Society of Nephrology : JASN, 5 7
-
J. Ortmann, K. Amann, R. Brandes, M. Kretzler, K. Münter, N. Parekh, T. Traupe, M. Lange, T. Lattmann, M. Barton (2004)
Role of Podocytes for Reversal of Glomerulosclerosis and Proteinuria in the Aging Kidney After Endothelin InhibitionHypertension, 44
-
J. Tang, A. Aitouche, V. Subbotin, A. Salam, H. Sun, C. Gandhi, L. Valdivia, J. Fung, T. Starzl, A. Rao (1999)
Endothelin-1 receptor blockade and its effect on chronic rejection.Transplantation proceedings, 31 1-2
-
K. Fukunaga, Y. Takada, H. Taniguchi, G. Mei, K. Seino, K. Yuzawa, M. Otsuka, T. Todoroki, K. Goto, K. Fukao (1999)
Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors.Transplantation, 67 2
-
W. Cefalu, G. Bray, P. Home, W. Garvey, S. Klein, F. Pi‐Sunyer, F. Hu, I. Raz, L. Gaal, B. Wolfe, D. Ryan (2015)
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors’ Expert ForumDiabetes Care, 38
-
M. Schlaich, D. Schmitt, C. Ott, B. Schmidt, R. Schmieder (2008)
Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humansJournal of Hypertension, 26
-
Camuglia (2013)
256Heart Lung Circ, 22
-
P. Ruggenenti, E. Porrini, F. Gaspari, N. Motterlini, A. Cannata, Fabiola Carrara, Claudia Cella, S. Ferrari, N. Stucchi, Aneliya Parvanova, I. Iliev, A. Dodesini, R. Trevisan, A. Bossi, J. Zaletel, G. Remuzzi (2012)
Glomerular Hyperfiltration and Renal Disease Progression in Type 2 DiabetesDiabetes Care, 35
-
N. El-Mahdy, Magda El-sayad, A. El-Kadem (2016)
Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 81
-
Steegers (2010)
631Lancet, 376
-
B. Rodriguez-Iturbe, A. Ferrebuz, Valentina Vanegas, Y. Quiroz, F. Espinoza, H. Pons, N. Vaziri (2005)
Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage.Kidney international, 68 5
-
R. Saran, James Novak, A. Desai, Emil Abdulhayoglu, J. Warren, R. Bustami, G. Handelman, Damian Barbato, W. Weitzel, L. D'alecy, S. Rajagopalan (2003)
Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 18 11
-
Kumano (1994)
2114Transplant Proc, 26
-
S. Maynard, J. Min, J. Merchan, K. Lim, Jianyi Li, S. Mondal, T. Libermann, James Morgon, F. Sellke, I. Stillman, F. Epstein, V. Sukhatme, A. Karumanchi (2003)
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.The Journal of clinical investigation, 111 5
-
A. Lerman, S. Kubo, L. Tschumperlin, J. Burnett (1992)
Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation.Journal of the American College of Cardiology, 20 4
-
M. Barton (2013)
Prevention and endothelial therapy of coronary artery disease.Current opinion in pharmacology, 13 2
-
W. White, D. Duprez, Richard Hillaire, S. Krause, B. Roniker, J. Kuse-Hamilton, M. Weber (2003)
Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic HypertensionHypertension: Journal of the American Heart Association, 41
-
S. Lankhorst, M. Kappers, J. Esch, Frank Smedts, S. Sleijfer, R. Mathijssen, H. Baelde, A. Danser, A. Meiracker (2014)
Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib: Preclinical StudyHypertension, 64
-
K. Fukunaga, Y. Takada, G. Mei, H. Taniguchi, K. Seino, K. Yuzawa, M. Otsuka, T. Todoroki, K. Goto, K. Fukao (1999)
An endothelin receptor antagonist ameliorates injuries of sinusoid lining cells in porcine liver transplantation.American journal of surgery, 178 1
-
P. Joris, J. Plat, Y. Kusters, A. Houben, C. Stehouwer, C. Schalkwijk, R. Mensink (2017)
Diet-induced weight loss improves not only cardiometabolic risk markers but also markers of vascular function: a randomized controlled trial in abdominally obese men.The American journal of clinical nutrition, 105 1
-
M. Kappers, J. Esch, W. Sluiter, S. Sleijfer, A. Danser, A. Meiracker (2010)
Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 LevelsHypertension, 56
-
T. Rabelink, H. Koomans (1997)
Endothelial function and the kidney. An emerging target for cardiovascular therapy.Drugs, 53 Suppl 1
-
Gaston (1995)
1426J Am Soc Nephrol, 5
- Publisher
- Wolters Kluwer Health
- Copyright
- Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
- ISSN
- 0263-6352
- eISSN
- 1473-5598
- DOI
- 10.1097/HJH.0000000000001600
- Publisher site
- See Article on Publisher Site
Abstract
After examining in Part I the general mechanisms of endothelial cell injury in the kidney, the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension and the Japanese Society of Hypertension will herein review current knowledge on the role of endothelial dysfunction in multiple disease conditions that affect the kidney, including diabetes mellitus, preeclampsia, solid organ transplantation, hyperhomocysteinemia and antiangiogenic therapy in cancer. The few available randomized controlled clinical trials specifically designed to evaluate strategies for correcting endothelial dysfunction in patients with hypertension and/or chronic kidney disease are also discussed alongside their cardiovascular and renal outcomes.
Journal
Journal of Hypertension – Wolters Kluwer Health
Published: Mar 1, 2018